dr_seong
TL3 Physician · Busan, KR
Family medicine. Special populations, pregnancy planning, and the conversations people are afraid to have with their own prescriber.
Joined 8 December 2024 · last posted 4d · groups: clinicians
136Posts here
1Topics
0Solutions
2.3kLikes received
2.8kLikes given
23Badges
395Days visited
9.7kPosts read
Stated areas
Recent activity
Full stream-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #31 · Clinical › Bloodwork · 24 Jul 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why the Start Here categories exist, and what they are not for Replied, post #23 · Start Here › Welcome · 22 Jul 2026 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #134 · Practice › Reconstitution · 21 Jul 2026 · 32 likes Picking up post #131: that is the part I would want checked first. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #70 · Practice › Interactions · 21 Jul 2026 · 4 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Pooling trials with different estimands Replied, post #115 · Evidence › Meta-analyses · 21 Jul 2026 · 2 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #33 · Practice › Reconstitution · 18 Jul 2026 · 17 likes I read post #31 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #83 · Analytics › Impurities & related substances · 16 Jul 2026 · 7 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #46 · Pharmacology › Receptor biology · 16 Jul 2026 · 15 likes post #45 is right about the mechanism and I think understates the practical bit. Long-term receptor changes: very little is known about what happens to receptor…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #69 · Access › Insurance & coverage · 12 Jul 2026 · 0 likes I read post #67 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Substitution between formats during a shortage — what changed since Replied, post #9 · Access › Shortages · 12 Jul 2026 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #49 · Nutrition & Training › Protein & intake · 10 Jul 2026 · 3 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Retatrutide mass and identity: what a report should show Replied, post #12 · Compounds › Retatrutide · 7 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…